Biodistribution and Radioimmunoimaging of 99Tcm-Labeled Anti-Progrp Monoclonal Antibody D-D3 in Nude Mice Bearing SCLC Xenografts
谢亦驰,周小林,郝丽君,洪智慧,沈明敬,徐忠恒,石怡珍,刘增礼
DOI: https://doi.org/10.3760/cma.j.issn.2095-2848.2015.05.006
2015-01-01
Abstract:Objective To explore the biodistribution and radioimmunoimaging of 99Tcm-labeled anti-ProGRP monoclonal antibody D-D3 in nude mice bearing human small cell lung cancer (SCLC) xenografts.Methods (1) D-D3 antibody was labeled with 99Tcm via the 2-mercaptoethanol reduction method.99Tcm-D-D3 was purified by the gel column separation method.The labeling efficiency,radiochemical purity,specific radioactivity and stability of 99Tcm-D-D3 were measured by thin-layer chromatography.Antigen-binding ability was determined by cell binding assay.(2)After tail vein injection of 99Tcm-D-D3,nude mice bearing SCLC NCI-H446 xenografts were sacrificed at designated time points.The blood and major organs were removed and weighed,and counted in a gamma scintillation counter.Radioactive uptake in each organ (％ID/g),tumor/muscle and tumor/blood ratios at each time point were calculated.(3)After injection of 99Tcm-D-D3,continuous imaging of the nude mice bearing NCI-H446 and lung adenocarcinoma A549 xenografts were carried out respectively,and the T/NT ratios were calculated.Two-sample t test was used to analyze the data.Results (1) The labeling rate of 99Tcm-D-D3 was (73.87±2.89)％.The radiochemical purity was (94.13±4.49) ％.The specific radioactivity was (1.64±0.06) MBq/μg.Being fully mixed with either saline or healthy human serum and incubated at 37 ℃ for 4 h,the radiochemical purities of 99Tcm-D-D3 were (82.17± 1.00) ％ and (74.13±1.67) ％ respectively,and (55.73± 1.07) ％ and (54.07± 1.88) ％ respectively after being incubated for 12 h.The immunobinding rates of 99Tcm-D-D3 to NCI-H446 and A549 cells were (81.20± 2.37) ％ and (24.30± 1.46) ％,respectively.(2) The ％ID/g of 99Tcm-D-D3 in NCI-H446 tumor was 2.13± 0.06,which was significantly higher than those of other organs except liver,kidneys,stomach and blood at 8 h after injection (t =2.52-24.53,all P＜0.05).The uptake in the tumors was higher than those of all other organs at 12 h (t=1.98-20.88,all P＜0.05),and reached the peak level (4.16±0.45) ％ID/g at 24 h.The tmor/muscle and tumor/blood ratios gradually increased with time.(3) At 2 h after injection of 99Tcm-D-D3,the tumor in NCI-H446 bearing nude mice could be visualized and definitely delineated at 4 h.The tumor uptake of 99Tcm-D-D3 gradually increased.No significant accumulation of 99Tcm-D-D3 was found in the A549 tumor mass from 1 to 24 h after injection.Conclusion 99Tcm-D-D3 can selectively accumulate in the tumor site of NCI-H446 xenografts and has a potential targeting property to SCLC.